Expression of complement components and inhibitors on platelet microparticles
about
Role of plasma kallikrein in diabetes and metabolismMegakaryocyte-derived microparticles: direct visualization and distinction from platelet-derived microparticlesComplement activation on platelets correlates with a decrease in circulating immature platelets in patients with immune thrombocytopenic purpuraComplement activation on platelets: implications for vascular inflammation and thrombosis.Autoantibody-mediated complement activation on platelets is a common finding in patients with immune thrombocytopenic purpura (ITP).Platelets in pulmonary vascular physiology and pathology.Antibodies against complement-regulatory proteins on platelets in immune thrombocytopenia.Requirements for membrane attack complex formation and anaphylatoxins binding to collagen-activated platelets.Biological properties of extracellular vesicles and their physiological functions.Platelet mediated complement activationPolyphosphate suppresses complement via the terminal pathway.Extracellular vesicle markers in relation to obesity and metabolic complications in patients with manifest cardiovascular diseaseCirculating microparticles: new insights into the biochemical basis of microparticle release and activity.The role of complement in the development and manifestation of murine atherogenic inflammation: novel avenues.Platelets, complement and tissue inflammation.Platelets and autoimmunity.Reincarnation of ancient links between coagulation and complement.Dangerous liaisons: complement, coagulation, and kallikrein/kinin cross-talk act as a linchpin in the events leading to thromboinflammation.Extracellular vesicles in renal disease.Routine Screening Method for Microparticles in Platelet Transfusions.Contact activation of C3 enables tethering between activated platelets and polymorphonuclear leukocytes via CD11b/CD18.Altered Flow Changes Thrombin Generation Rate of Circulating Platelets.
P2860
Q27016431-72DA4B80-19BD-4E15-A241-192D9D6CED9BQ30485800-00220DCA-2E75-4136-A0D5-613D0B817505Q33387105-056AFA63-9CB4-40C9-92A3-4AF717A144B2Q33390662-0654EBE5-DC48-488F-AFCE-5198432E439DQ33397553-3BE01AA1-CC47-4162-8DB5-D8444AF32990Q33404240-ED6BE267-6DA3-4CBB-962A-3833A71F9ACFQ33435999-4987BA78-92AA-479D-B5AD-BE2A406BF8FCQ33883732-CDB0F572-DB97-48A0-A97B-815053252FF9Q35611763-91D77504-361B-43C7-A386-73323C27855EQ37088046-77B870C1-210C-4174-A535-008972C8DB15Q37535268-D8E7BB62-DA26-430C-AFDF-E5B4A57FC1A3Q37568849-ECEC9654-9235-4885-A3CF-D48B011B7E6AQ37892456-C35110E6-5FE5-4994-9026-F0F59B288971Q37960811-74B93049-39EE-4BB1-9657-3DD0F813EB6BQ38038674-36C34A45-E3C3-49FE-B158-D3A680EB8893Q38101678-AB458A80-B884-44B3-AB0B-C79ED13C986BQ38543278-EA22593C-834F-46FD-9C80-054BDA6AB684Q38991010-D9C9694E-03E2-4E86-8E82-B47CE8532E26Q39453434-0B7B9B2D-E2B1-4326-9094-CFDFD43BFCD2Q50010568-3CCA278F-69CC-4320-A49B-1F2049532F1BQ51741449-C0607FFD-EBF7-49AD-BFC9-9F1489F67EFCQ53480847-EAF514AC-AC48-4369-AD60-9C2B94216C00
P2860
Expression of complement components and inhibitors on platelet microparticles
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Expression of complement components and inhibitors on platelet microparticles
@en
Expression of complement components and inhibitors on platelet microparticles.
@nl
type
label
Expression of complement components and inhibitors on platelet microparticles
@en
Expression of complement components and inhibitors on platelet microparticles.
@nl
prefLabel
Expression of complement components and inhibitors on platelet microparticles
@en
Expression of complement components and inhibitors on platelet microparticles.
@nl
P2093
P2860
P1433
P1476
Expression of complement components and inhibitors on platelet microparticles
@en
P2093
Berhane Ghebrehiwet
Ellinor I B Peerschke
P2860
P304
P356
10.1080/09537100701777311
P577
2008-05-01T00:00:00Z